WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-463 Cr |
| Mar2024 | ₹-559 Cr |
| Mar2023 | ₹-244 Cr |
| Mar2022 | ₹686 Cr |
| Mar2021 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-463 Cr | Negative | |
| Mar2024 | ₹-559 Cr | Negative | |
| Mar2023 | ₹-244 Cr | Negative | |
| Mar2022 | ₹686 Cr | Positive | |
| Mar2021 | ₹-69 Cr | - | |
Compare Consolidated Net Profit of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,420.1 Cr | 2.5% | 0.1% | -0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 2.5% |
0.1% |
-0.3% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses